Michigan Medicine Selects Mach7’s eUnity SMARTviewer to Drive Enterprise Viewing Strategy

NEXT STORY
Worldwide Post-Pandemic Healthcare Market Study 2020 – COVID-19 Impact
PREV STORY
Affimed Announces Two New Appointments to Its Supervisory Board
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Chiasma Announces First Patient Is Randomized in Phase 3 CHIASMA OPTIMAL Clinical Trial of Octreotide Capsules in Patients with Acromegaly

WALTHAM, Mass., Sept. 27, 2017 (GLOBE NEWSWIRE) -- Chiasma, Inc. (Nasdaq:CHMA), a clinical-stage biopharmaceutical ...

author_avatar
NASDAQ Market News

FDA Accepts Emergent BioSolutions’ Supplemental Biologics License Application for Large-Scale Manufacturing of BioThrax in Building 55

GAITHERSBURG, Md., June 17, 2016 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced ...

author_avatar
NASDAQ Market News

Atara Bio Announces Participation in Two Upcoming Immuno-Oncology Conferences

SOUTH SAN FRANCISCO, Calif., March 28, 2016 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq:ATRA), ...

author_avatar
NASDAQ Market News